Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation... by M. S. A. Niemantsverdriet (11886431)

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Top 20 genes with significantly increased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Number and % of participants demonstrating a clinically-significant difference on RMSSD HRV (comparing compassion or relaxation task to control). by Iona Naismith (14581268)

Subjects:

List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample. by Masaya Nagaya (13851123)

Roughness change in means of Ra (nm) and RMS (nm) for both tested systems. (different capital superscript letters indicate within group significancy, different lower-case superscri... by Beliz Özel (16475132)

Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

“…The orange color indicates increase in levels and the blue color represent decrease in levels. …”

Clinical and laboratory measurements of patients with ALS (N = 13; Mean±SD; ns = not significant; nd = not determined; * = evidence of subgroup responsiveness). by Ann Logan (9361)

Perioperative changes in CLSS questionnaire results stratified by uroflowmetry parameter changes. by Yuta Takeshima (818627)

Subjects:

Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

Subjects:

Self-reported affect change during CFI for participants who attended multiple sessions (N = 22). by Iona Naismith (14581268)

Subjects:

Demographic, biochemical and clinical characteristics of the study groups. by Azza Elamir (13924199)

Subjects:

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. by Soheila Qanbari (20455173)

Subjects:

TGF-β1 increases levels of miR-22-3p and decreases change in human mammary epithelial cell count. by Rhea Sullivan (18824253)

PoRVA infection induces significant changes in cellular metabolites in IPEC-J2 cells. by Haixin Liu (7571234)

TBSS results showing significant AxD and RD changes at baseline and the follow-up. by Sewon Lim (21989785)

Subjects:

The demographical and clinical characteristics of subjects at baseline. by Soheila Qanbari (20455173)

Subjects:

Changes in uroflowmetry results stratified by predictive factors. by Yuta Takeshima (818627)

Subjects:

Weights did not vary significantly during PPS treatment. by Penny A. Rudd (10298691)

Changes between pre- and post-RARP uroflowmetry parameters. by Yuta Takeshima (818627)

Subjects: